Pay in 4 interest-free payments of $6.25 Learn more
Ships within 48 hours · Estimated delivery Nov 7 - Nov 12
Co-corresponding author and co-first author Fabio Hecht, PhD, and co-first author Marco Zocchi, PhD, led the study in the Harris lab in the Department of Biomedical Genetics
Striking the balance: GLP-1/Glucagon Co-agonism as a treatment strategy for obesity
The underlying mechanism appears similar across GLP-1 medications
A 2024 study published by Malhotra in The New England Journal of Medicine found that up to half of people who took Zepbound for a year saw their sleep apnea improve to a point where they might even be able to stop their CPAP therapy
It highlights recent safety labeling changes
US$ 23.43
US$ 21.81
US$ 29.34
